Pelion to be delisted from WSE

The Warsaw Stock Exchange approved pharma group Pelion’s motion to delist the company shares from the bourse effective from September 29. The company filed such request after its shareholders tendered enough shares in its May buyback offer to conduct the mandatory squeeze-out which led to delisting. Pelion is a pharmaceutical producer active on the Polish and Lithuanian market. It also operates Drogeria Natura drugstore chain as well as a chain of pharmacies.